A cluster randomised trial of cloth masks compared with medical masks in healthcare workers

C Raina MacIntyre, Holly Seale, Tham Chi Dung, Nguyen Tran Hien, Phan Thi Nga, Abrar Ahmad Chughtai, Bayzidur Rahman, Dominic E Dwyer, Quanyi Wang, C Raina MacIntyre, Holly Seale, Tham Chi Dung, Nguyen Tran Hien, Phan Thi Nga, Abrar Ahmad Chughtai, Bayzidur Rahman, Dominic E Dwyer, Quanyi Wang

Abstract

Objective: The aim of this study was to compare the efficacy of cloth masks to medical masks in hospital healthcare workers (HCWs). The null hypothesis is that there is no difference between medical masks and cloth masks.

Setting: 14 secondary-level/tertiary-level hospitals in Hanoi, Vietnam.

Participants: 1607 hospital HCWs aged ≥18 years working full-time in selected high-risk wards.

Intervention: Hospital wards were randomised to: medical masks, cloth masks or a control group (usual practice, which included mask wearing). Participants used the mask on every shift for 4 consecutive weeks.

Main outcome measure: Clinical respiratory illness (CRI), influenza-like illness (ILI) and laboratory-confirmed respiratory virus infection.

Results: The rates of all infection outcomes were highest in the cloth mask arm, with the rate of ILI statistically significantly higher in the cloth mask arm (relative risk (RR)=13.00, 95% CI 1.69 to 100.07) compared with the medical mask arm. Cloth masks also had significantly higher rates of ILI compared with the control arm. An analysis by mask use showed ILI (RR=6.64, 95% CI 1.45 to 28.65) and laboratory-confirmed virus (RR=1.72, 95% CI 1.01 to 2.94) were significantly higher in the cloth masks group compared with the medical masks group. Penetration of cloth masks by particles was almost 97% and medical masks 44%.

Conclusions: This study is the first RCT of cloth masks, and the results caution against the use of cloth masks. This is an important finding to inform occupational health and safety. Moisture retention, reuse of cloth masks and poor filtration may result in increased risk of infection. Further research is needed to inform the widespread use of cloth masks globally. However, as a precautionary measure, cloth masks should not be recommended for HCWs, particularly in high-risk situations, and guidelines need to be updated.

Trial registration number: Australian New Zealand Clinical Trials Registry: ACTRN12610000887077.

Keywords: Cloth mask; Influenza.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Figures

Figure 1
Figure 1
Consort diagram of recruitment and follow-up (HCWs, healthcare workers).
Figure 2
Figure 2
Outcomes in trial arms (CRI, clinical respiratory illness; ILI, influenza-like illness; Virus, laboratory-confirmed viruses).
Figure 3
Figure 3
Compliance with the mask wearing—mask wearing more than 70% of working hours.

References

    1. World Health Organization (WHO). Global Alert and Response (GAR), Pandemic (H1N1) 2009—update 76 (cited 27 Apr 2012).
    1. World Health Organization (WHO). Human infection with avian influenza A(H7N9) virus—update (cited 8 May 2013).
    1. Bermingham A, Chand MA, Brown CS et al. . Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill 2012;17:20290.
    1. Pollack MP, Pringle C, Madoff LC et al. . Latest outbreak news from ProMED-mail: novel coronavirus—Middle East. Int J Infect Dis 2013;17:e143–4. 10.1016/j.ijid.2012.12.001
    1. World Health Organization (WHO). Global Alert and Response (GAR). Ebola virus disease update—west Africa 2014 (cited 28 Aug 2014).
    1. Chughtai AA, Seale H, MacIntyre CR. Use of cloth masks in the practice of infection control—evidence and policy gaps. Int J Infect Control 2013;9:1–12.
    1. Quesnel LB. The efficiency of surgical masks of varying design and composition. Br J Surg 1975;62:936–40. 10.1002/bjs.1800621203
    1. MacIntyre CR, Wang Q, Cauchemez S et al. . A cluster randomized clinical trial comparing fit-tested and non-fit-tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers. Influenza Other Respir Viruses 2011;5:170–9. 10.1111/j.1750-2659.2011.00198.x
    1. MacIntyre CR, Wang Q, Seale H et al. . A randomised clinical trial of three options for N95 respirators and medical masks in health workers. Am J Respir Crit Care Med 2013;187:960–6. 10.1164/rccm.201207-1164OC
    1. Chughtai AA, MacIntyre CR, Zheng Y et al. . Examining the policies and guidelines around the use of masks and respirators by healthcare workers in China, Pakistan and Vietnam. J Infect Prev 2015;16:68–74.
    1. Chughtai AA, Seale H, Chi Dung T et al. . Current practices and barriers to the use of facemasks and respirators among hospital-based health care workers in Vietnam. Am J Infect Control 2015;43:72–7. 10.1016/j.ajic.2014.10.009
    1. Pang X, Zhu Z, Xu F et al. . Evaluation of control measures implemented in the severe acute respiratory syndrome outbreak in Beijing. JAMA 2003;290:3215–21. 10.1001/jama.290.24.3215
    1. Yang P, Seale H, MacIntyre C et al. . Mask-wearing and respiratory infection in healthcare workers in Beijing, China. Braz J Infect Dis 2011;15:102–8. 10.1016/S1413-8670(11)70153-2
    1. Horton R. Medical journals: evidence of bias against the diseases of poverty. Lancet 2003;361:712–13. 10.1016/S0140-6736(03)12665-7
    1. MacIntyre CR, Chughtai AA. Facemasks for the prevention of infection in healthcare and community settings. BMJ 2015;350:h694.
    1. Chughtai AA, Seale H, MacIntyre CR. Availability, consistency and evidence-base of policies and guidelines on the use of mask and respirator to protect hospital health care workers: a global analysis. BMC Res Notes 2013;6:1–9. 10.1186/1756-0500-6-216
    1. MacIntyre C, Cauchemez S, Dwyer D et al. . Face mask use and control of respiratory virus transmission in households. Emerg Infect Dis 2009;15:233–41. 10.3201/eid1502.081166
    1. Buecher C, Mardy S, Wang W, et al. Use of a multiplex PCR/RT-PCR approach to assess the viral causes of influenza-like illnesses in Cambodia during three consecutive dry seasons. J Med Virol 2010;82:1762-72 [Epub ahead of print 1 Sep 2010].
    1. Higuchi R, Fockler C, Dollinger G, et al. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (N Y) 1993;11:1026–30 [Epub ahead of print 1 Sep 2010].
    1. Hummel KB, Lowe L, Bellini WJ, et al. Development of quantitative gene-specific real-time RT-PCR assays for the detection of measles virus in clinical specimens. J Virol Methods 2006;132:166–73 [Epub ahead of print 11 Sep 2005].
    1. Mackay IM. Real-time PCR in microbiology. Caister Academic Press, 2007.
    1. Wang W, Cavailler P, Ren P, et al. Molecular monitoring of causative viruses in child acute respiratory infection in endemo-epidemic situations in Shanghai. J Clin Virol (PASCV) 2010;49:211–8.
    1. Thi TN, Deback C, Malet I et al. . Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR. Antiviral Res 2006;69:152–7. 10.1016/j.antiviral.2005.11.004
    1. Standards Australia Limited/Standards New Zealand. Respiratory protective devices. Australian/New Zealand Standard. AS/NZS 1716: 2012.
    1. Donner A, Klar N. Design and analysis of cluster randomization trials in health research. London: Oxford University Press Inc, 2000.
    1. Campbell MK, Elbourne DR, Altman DG et al. . CONSORT statement: extension to cluster randomised trials. BMJ 2004;328:702–8.
    1. Vittinghoff E, Glidden DV, Shiboski SC et al. . Regression methods in biostatistics. 2nd edn New York: Springer-Verlag, 2012.
    1. StataCorp. Stata 12 base reference manual. College Station, TX: Stata Press, 2011.
    1. Osterholm MT, Moore KA, Kelley NS et al. . Transmission of Ebola viruses: what we know and what we do not know. mBio 2015;6:e00137–15. 10.1128/mBio.00137-15
    1. Fisher EM, Noti JD, Lindsley WG et al. . Validation and application of models to predict facemask influenza contamination in healthcare settings. Risk Anal 2014;34:1423–34. 10.1111/risa.12185
    1. Li Y, Wong T, Chung J et al. . In vivo protective performance of N95 respirator and surgical facemask. Am J Ind Med 2006;49:1056–65. 10.1002/ajim.20395
    1. Dick EC, Jennings LC, Mink KA et al. . Aerosol transmission of rhinovirus colds. J Infect Dis 1987;156:442–8. 10.1093/infdis/156.3.442
    1. Bischoff WE. Transmission route of rhinovirus type 39 in a monodispersed airborne aerosol. Infect Control Hosp Epidemiol 2010;31:857–9. 10.1086/655022
    1. Institute of Medicine (IOM). Reusability of Facemasks During an Influenza Pandemic: Facing the Flu—Committee on the Development of Reusable Facemasks for Use During an Influenza Pandemic. National Academy of Sciences, 2006.
    1. Center for Disease Control and Prevention and World Health Organization. Infection control for viral haemorrhagic fevers in the African health care setting. Atlanta: Centers for Disease Control and Prevention, 1998:1–198.
    1. World Health Organization (WHO). Guidelines for the prevention of tuberculosis in health care facilities in resource limited settings, 1999.
    1. Weaver GH. Droplet infection and its prevention by the face mask. J Infect Dis 1919;24:218–30. 10.1093/infdis/24.3.218
    1. MacIntyre CR, Chughtai AA, Seale H et al. . Respiratory protection for healthcare workers treating Ebola virus disease (EVD): are facemasks sufficient to meet occupational health and safety obligations? Int J Nurs Stud 2014;51: 1421–6. 10.1016/j.ijnurstu.2014.09.002
    1. Center for Disease Control and Prevention (CDC). Guidance on Personal Protective Equipment To Be Used by Healthcare Workers During Management of Patients with Ebola Virus Disease in U.S. Hospitals, Including Procedures for Putting On (Donning) and Removing (Doffing). 2014 (cited 23 Oct 2014).
    1. World Health Organiszation (WHO). Infection prevention and control guidance for care of patients in health-care settings, with focus on Ebola. 2014 (cited 23 Oct 2014).

Source: PubMed

3
Subskrybuj